Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Victoria L. Parker"'
Autor:
Victoria L. Parker, Matthew C. Winter, John A. Tidy, Barry W. Hancock, Julia E. Palmer, Naveed Sarwar, Baljeet Kaur, Katie McDonald, Xianne Aguiar, Kamaljit Singh, Nick Unsworth, Imran Jabbar, Allan A. Pacey, Robert F. Harrison, Michael J. Seckl
Publikováno v:
International journal of cancerREFERENCES. 152(5)
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is
Autor:
Victoria L. Parker, Bryony F. Cushen, Annie Hills, Kaveetha Kandiah, Julia E. Palmer, Kamaljit Singh, Barry W. Hancock, John A. Tidy, Matthew C. Winter
Publikováno v:
Gynecologic oncology. 169
Single-agent methotrexate (MTX) is commonly used as first-line treatment for low-risk gestational trophoblastic neoplasia (LR-GTN), although no international consensus exists on the optimal treatment regimen to maximise complete hCG response (CR) and
Autor:
Victoria L. Parker, John A. Tidy
Publikováno v:
Obstetrics, Gynaecology & Reproductive Medicine. 31:21-29
Autor:
Allan A. Pacey, Elspeth H. Whitby, William A E Parker, Barry W. Hancock, Matthew C Winter, John Tidy, Julia E. Palmer, Victoria L. Parker, Robert F. Harrison
Publikováno v:
British Journal of Cancer
Background The International Federation of Gynaecology and Obstetrics (FIGO) score identifies gestational trophoblastic neoplasia (GTN) patients as low- or high-risk of single-agent chemotherapy resistance (SACR). Computed tomography (CT) has greater
Autor:
Suneetha Rachaneni, Shanteela McCooty, Lee J Middleton, Victoria L Parker, Jane P Daniels, Arri Coomarasamy, Tina S Verghese, Moji Balogun, Ilias Goranitis, Pelham Barton, Tracy E Roberts, Jonathan J Deeks, Pallavi Latthe, on behalf of the Bladder Ultrasound Study (BUS) Collaborative Group
Publikováno v:
Health Technology Assessment, Vol 20, Iss 7 (2016)
Background: Urodynamics (UDS) has been considered the gold standard test for detrusor overactivity (DO) in women with an overactive bladder (OAB). Bladder ultrasonography to measure bladder wall thickness (BWT) is less invasive and has been proposed
Externí odkaz:
https://doaj.org/article/12c889114c1343f992c0c3545475ac3b
Autor:
Bryony F. Cushen, Sarah L. Waite, Eleftherios Gavriil, Benjamin Marshall, Victoria L. Parker, Allan A. Pacey, Paul R. Heath
Publikováno v:
Molecular Medicine Reports
Circulating microRNA (miRNA) biomarkers are implicated in the diagnosis, monitoring and prediction of various disease processes. Before embarking upon biomarker discovery, miRNA extraction techniques must first be optimised in the biofluid and popula
Publikováno v:
Biomed Rep
Blood-derived microRNAs (miRNAs/miRs) are ideal clinical biomarkers, as they can be relatively non-invasively extracted and are stable across a range of storage conditions. However, the concentration and profile of miRNAs differ between specific pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd72a978d9a5c3297b44fc5061a0ef0
https://europepmc.org/articles/PMC7780752/
https://europepmc.org/articles/PMC7780752/
Publikováno v:
The Journal of laryngology and otology.
BackgroundThis paper discusses the concept of acoustic shock based on a literature review and the results of our own research into cases seen in both clinical and medicolegal practice. With the demise of traditional ‘metal bashing’ and ‘smoke s
Autor:
Matthew C Winter, Philip Savage, Naveed Sarwar, Dee Short, Barry W. Hancock, Nicholas Unsworth, John Tidy, Xianne Aguiar, Rosemary A. Fisher, Ailsa Sita-Lumsden, Robert E. Coleman, Victoria L. Parker, Richard A. Harvey, Victoria Harding, Michael J. Seckl
Publikováno v:
BJOG : an international journal of obstetrics and gynaecologyReferences. 127(9)
Objective\ud To investigate the demographics, natural history and treatment outcomes of non‐molar gestational choriocarcinoma.\ud \ud Design\ud A retrospective national population‐based study.\ud \ud Setting\ud UK 1995–2015.\ud \ud Population\u
Autor:
John Tidy, Victoria L. Parker
Publikováno v:
Obstetrics, Gynaecology & Reproductive Medicine. 27:338-345
Gestational trophoblastic disease incorporates a spectrum of disorders ranging from benign to malignant subtypes. At one end, hCG level monitoring is all that is required, whereas, at the other, patients require combination chemotherapy regimens and